Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE

NCT00687609 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
7
Enrollment
INDUSTRY
Sponsor class

Stopped The study was discontinued early, owing to difficulties in recruiting the target sample after seven patients had been recruited.

Conditions

Interventions

Sponsor

Eli Lilly and Company